Fluorouracil/NivolumabLack of efficacy: case report

被引：0

作者：

机构：

来源：

Reactions Weekly | 2025年 / 2056卷 / 1期

关键词：

D O I：

10.1007/s40278-025-81580-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：208 / 208

相关论文

共 50 条

[21] Catequentinib/nivolumabLack of efficacy: case report
Reactions Weekly, 2022, 1910 (1) : 129 - 129
[22] Ipilimumab/NivolumabLack of efficacy: case report
Reactions Weekly, 2025, 2064 (1) : 186 - 186
[23] Ipilimumab/nivolumabLack of efficacy: case report
Reactions Weekly, 2022, 1917 (1) : 323 - 323
[24] Lomustine/nivolumabLack of efficacy: case report
Reactions Weekly, 2022, 1918 (1) : 295 - 295
[25] Ipilimumab/nivolumabLack of efficacy: case report
Reactions Weekly, 2022, 1908 (1) : 304 - 304
[26] Ipilimumab/nivolumabLack of efficacy: case report
Reactions Weekly, 2024, 2034 (1) : 186 - 186
[27] Ipilimumab/nivolumabLack of efficacy: case report
Reactions Weekly, 2021, 1874 (1) : 148 - 148
[28] Ipilimumab/nivolumabLack of efficacy: case report
Reactions Weekly, 2022, 1923 (1) : 271 - 271
[29] Ipilimumab/nivolumabLack of efficacy: case report
Reactions Weekly, 2022, 1924 (1) : 258 - 258
[30] Ipilimumab/nivolumabLack of efficacy: case report
Reactions Weekly, 2024, 2032 (1) : 223 - 223

← 1 2 3 4 5 →